A 2-year multicenter, observational, prospective, cohort study on extracorporeal CO
Acute respiratory distress syndrome
COPD exacerbation
Extracorporeal CO2 removal
Safety
Journal
Journal of intensive care
ISSN: 2052-0492
Titre abrégé: J Intensive Care
Pays: England
ID NLM: 101627304
Informations de publication
Date de publication:
2019
2019
Historique:
received:
22
03
2019
accepted:
12
08
2019
entrez:
28
8
2019
pubmed:
28
8
2019
medline:
28
8
2019
Statut:
epublish
Résumé
Extracorporeal carbon dioxide removal (ECCO To assess on a structural basis the rate of utilization as well as efficacy and safety parameters of 2 ECCO Seventy patients were recruited in 10 voluntary and specifically trained centers. The median utilization rate was 0.19 patient/month/center (min 0.04; max 1.20). ECCO Based on a registry, we report a low rate of ECCO ClinicalTrials.gov: Identifier: NCT02965079 retrospectively registered https://clinicaltrials.gov/ct2/show/NCT02965079.
Sections du résumé
BACKGROUND
BACKGROUND
Extracorporeal carbon dioxide removal (ECCO
METHODS
METHODS
To assess on a structural basis the rate of utilization as well as efficacy and safety parameters of 2 ECCO
RESULTS
RESULTS
Seventy patients were recruited in 10 voluntary and specifically trained centers. The median utilization rate was 0.19 patient/month/center (min 0.04; max 1.20). ECCO
CONCLUSIONS
CONCLUSIONS
Based on a registry, we report a low rate of ECCO
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov: Identifier: NCT02965079 retrospectively registered https://clinicaltrials.gov/ct2/show/NCT02965079.
Identifiants
pubmed: 31452899
doi: 10.1186/s40560-019-0399-8
pii: 399
pmc: PMC6701003
doi:
Banques de données
ClinicalTrials.gov
['NCT02965079']
Types de publication
Journal Article
Langues
eng
Pagination
45Déclaration de conflit d'intérêts
Competing interestsDr. Diehl reported receiving research support and personal fees from Alung and Novalung/Xenios.
Références
Anesthesiology. 2009 Oct;111(4):826-35
pubmed: 19741487
Intensive Care Med. 2012 Oct;38(10):1632-9
pubmed: 22836139
Intensive Care Med. 2013 May;39(5):847-56
pubmed: 23306584
Chest. 2013 Mar;143(3):678-686
pubmed: 23460154
Perfusion. 2014 Jan;29(1):26-8
pubmed: 23842616
Crit Care Med. 2014 Jun;42(6):e451-60
pubmed: 24705570
Crit Care Med. 2015 Jan;43(1):120-7
pubmed: 25230375
Rev Mal Respir. 2014 Oct;31(8):779-95
pubmed: 25391514
Intensive Care Med. 2015 Oct;41(10):1752-62
pubmed: 26109400
Intensive Care Med. 2016 Apr;42(4):624-625
pubmed: 26831671
Crit Care. 2016 Feb 10;20:36
pubmed: 26861596
Intensive Care Med. 2016 May;42(5):951-952
pubmed: 26873832
Intensive Care Med. 2016 Sep;42(9):1437-44
pubmed: 27456703
Intensive Care Med. 2016 Dec;42(12):1865-1876
pubmed: 27757516
Intensive Care Med. 2017 Apr;43(4):519-530
pubmed: 28132075
ASAIO J. 2017 Sep/Oct;63(5):666-671
pubmed: 28187047
Minerva Anestesiol. 2017 Jul;83(7):762-772
pubmed: 28402093
Respir Care. 2017 Sep;62(9):1178-1185
pubmed: 28559467
Am J Respir Crit Care Med. 2017 Sep 1;196(5):558-568
pubmed: 28636403
J Intensive Care. 2017 Aug 8;5:53
pubmed: 28808576
Medicine (Baltimore). 2017 Oct;96(41):e8248
pubmed: 29019893
Crit Care. 2018 May 10;22(1):122
pubmed: 29743094
J Intensive Care. 2018 Jun 28;6:36
pubmed: 29988327
Lancet Respir Med. 2018 Nov;6(11):874-884
pubmed: 30484429
Intensive Care Med. 2019 May;45(5):592-600
pubmed: 30790030